Infectious Dis. Medical News about Bacillus anthracis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Proteomic studies of Bacillus anthracis
Future Microbiology, 11/02/09

Chitlaru T et al. – The studies included comparison of strains differing in their virulence, cultured under different conditions and, in some cases, were complemented by serological inspection, which addressed expression during infection of proteomically identified proteins and their immunogenicity. The proteomic approach emerged as a valuable strategy for the generation of a pool of potential B. anthracis protein targets for further evaluation in detection, diagnostics, therapy and prophylaxis, and contributed to the elucidation of some aspects of the pathogenesis of the disease.

<< Previous
ABO phenotype and sepsis in very low birth infants

Next >>
Multicenter evaluation of the ENTEROVIRUS R-gene? real-time...

Staphylococcus aureus synthesizes adenosine to escape host immune responses
Journal of Experimental Medicine, 11/04/09 Relevance Score: 64%

Response of Bacillus cereus ATCC 14579 to challenges with sublethal concentrations of enterocin AS-48
BMC Microbiology, 10/30/09 Relevance Score: 42%

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model
The Journal of Urology, 10/19/09 Relevance Score: 42%

Protein Expression Patterns of Ezrin Are Predictors of Progression in T1G3 Bladder Tumours Treated with Nonmaintenance Bacillus Calmette-Gurin
European Urology, 10/16/09 Relevance Score: 42%

Sensitivity of breast cancer cell lines to recombinant thiaminase I
Cancer Chemotherapy and Pharmacology, 10/20/09 Relevance Score: 40%